Mach7 Technologies Limited (M7T) 2022年年度报告「ASX」.pdf

1、AnnualReport2021/22(ASX:M7T)ABN 007 817 For personal use onlyFor personal use onlyMach7 Technologies is a medical imaging company that develops innovative visualisation and data management solutions that connect patient information and clinicians,promoting high quality care and better health outcome

2、s.We help healthcare providers drive enterprise imaging forward in a strategic way,moving beyond technology deployment to achieving a mature strategy that includes all the structural building blocks of success.For personal use onlyFor personal use onlyMach7 Technologies Annual Report 2021/221Table o

3、f ContentsKey Achievements in FY22Letter from the ChairmanAbout Mach7Why Customers Choose Mach7People and LocationsPatient-Centric Enterprise Imaging with a Global PresenceA Global Customer NetworkOur PartnersThe Mach7 Value PropositionThe Mach7 Product Suite-Enterprise Imaging SolutionExecutive Lea

4、dership TeamBoard of DirectorsMach7 at a GlanceFinancial PerformanceOrganisational Overview and External EnvironmentOur Business StrategiesRisk ManagementFinancial Report 2021/2022Directors ReportRemuneration Report(Audited)Auditors Independence DeclarationStatement of Profit and Loss and Other Comp

5、rehensive IncomeStatement of Financial PositionStatement of Changes in EquityStatement of CashflowsNotes to the Financial StatementsDirectors DeclarationIndependent Auditors ReportCorporate Governance StatementAdditional Shareholder InformationCorporate Directory02 0811121314151617182225272832343536

6、37425556575859609899104105109For personal use onlyFor personal use onlyMach7 Technologies Annual Report 2021/222Key Achievements in FY22Key Achievements in FY22Third Consecutive Year of Positive Cashflows Third consecutive year of positive operating cashflows;up 320%to$6.3M Highest ever cash receipt